Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PFE

Pfizer

$36.41

-0.04 (-0.11%)

, AGLE

Aeglea BioTherapeutics

$5.25

0.18 (3.55%)

04:55
01/10/18
01/10
04:55
01/10/18
04:55
Conference/Events
EBD Group to hold a conference »

Biotech Showcase 2018 is…

PFE

Pfizer

$36.41

-0.04 (-0.11%)

AGLE

Aeglea BioTherapeutics

$5.25

0.18 (3.55%)

BMRN

BioMarin

$89.14

0.505 (0.57%)

RXII

RXi Pharmaceuticals

$4.41

-0.0999 (-2.22%)

NAVB

Navidea

CLRB

Cellectar Biosciences

$1.19

-0.0601 (-4.81%)

EBIO

Eleven Biotherapeutics

$0.86

-0.0102 (-1.17%)

PSDV

pSivida

VTGN

VistaGen Therapeutics

$1.19

0.08 (7.21%)

SPHS

Sophiris Bio

$2.27

-0.13 (-5.42%)

ABMD

Abiomed

$209.76

1.96 (0.94%)

AYTU

Aytu BioScience

$2.36

-0.11 (-4.45%)

TROV

Trovagene

$0.34

-0.0175 (-4.90%)

KOOL

Cesca Therapeutics

$3.79

0.4383 (13.08%)

SFE

Safeguard Scientifics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 25

    Jan

  • 30

    Jan

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

  • 16

    Feb

  • 28

    Feb

  • 25

    May

PFE

Pfizer

$36.45

-0.41 (-1.11%)

, AGLE

Aeglea BioTherapeutics

$5.07

-0.45 (-8.15%)

04:55
01/09/18
01/09
04:55
01/09/18
04:55
Conference/Events
EBD Group to hold a conference »

Biotech Showcase 2018 is…

PFE

Pfizer

$36.45

-0.41 (-1.11%)

AGLE

Aeglea BioTherapeutics

$5.07

-0.45 (-8.15%)

BMRN

BioMarin

$88.64

-1.635 (-1.81%)

RXII

RXi Pharmaceuticals

$4.51

4.0412 (862.03%)

NAVB

Navidea

CLRB

Cellectar Biosciences

$1.25

-0.0599 (-4.57%)

EBIO

Eleven Biotherapeutics

$0.87

-0.0066 (-0.75%)

PSDV

pSivida

$1.10

-0.02 (-1.79%)

VTGN

VistaGen Therapeutics

$1.11

-0.01 (-0.89%)

SPHS

Sophiris Bio

$2.40

-0.04 (-1.64%)

ABMD

Abiomed

$207.80

5.48 (2.71%)

AYTU

Aytu BioScience

$2.47

-0.11 (-4.26%)

TROV

Trovagene

$0.36

-0.0262 (-6.83%)

KOOL

Cesca Therapeutics

$3.35

0.14 (4.36%)

SFE

Safeguard Scientifics

$11.05

-0.2 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 25

    Jan

  • 30

    Jan

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

  • 16

    Feb

  • 28

    Feb

  • 25

    May

PFE

Pfizer

$36.86

0.07 (0.19%)

, AGLE

Aeglea BioTherapeutics

$5.52

-0.17 (-2.99%)

08:11
01/08/18
01/08
08:11
01/08/18
08:11
Conference/Events
EBD Group to hold a conference »

Biotech Showcase 2018 is…

PFE

Pfizer

$36.86

0.07 (0.19%)

AGLE

Aeglea BioTherapeutics

$5.52

-0.17 (-2.99%)

BMRN

BioMarin

$90.27

-0.05 (-0.06%)

RXII

RXi Pharmaceuticals

$0.47

-0.0452 (-8.79%)

NAVB

Navidea

$0.39

0.01 (2.63%)

CLRB

Cellectar Biosciences

EBIO

Eleven Biotherapeutics

$0.88

0.0156 (1.81%)

PSDV

pSivida

$1.12

-0.01 (-0.88%)

VTGN

VistaGen Therapeutics

SPHS

Sophiris Bio

$2.44

0.1301 (5.63%)

ABMD

Abiomed

$202.32

3.07 (1.54%)

AYTU

Aytu BioScience

$2.58

0.0301 (1.18%)

TROV

Trovagene

$0.38

0.0246 (6.85%)

KOOL

Cesca Therapeutics

$3.21

0.06 (1.90%)

SFE

Safeguard Scientifics

$11.25

-0.05 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

  • 09

    Jan

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 16

    Feb

  • 28

    Feb

  • 25

    May

RXII

RXi Pharmaceuticals

$0.51

-0.0114 (-2.17%)

12:47
01/05/18
01/05
12:47
01/05/18
12:47
Hot Stocks
RXi Pharmaceuticals announces 1-for-10 reverse stock split »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

Over a month ago
RXII

RXi Pharmaceuticals

$0.62

-0.01 (-1.59%)

07:11
12/18/17
12/18
07:11
12/18/17
07:11
Hot Stocks
RXi Pharma says Phase 2 trial of RXI-109 meets primary effectiveness objective »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$0.63

0.057 (10.00%)

07:12
12/11/17
12/11
07:12
12/11/17
07:12
Hot Stocks
RXi Pharmaceuticals enters research collaboration with Medigene AG »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$0.63

-0.0544 (-8.00%)

07:07
12/01/17
12/01
07:07
12/01/17
07:07
Hot Stocks
RXi Pharmaceuticals, CCIT at Herlev Hospital announce research collaboration »

RXi Pharmaceuticals and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$0.67

-0.04 (-5.63%)

07:06
11/29/17
11/29
07:06
11/29/17
07:06
Hot Stocks
RXi Pharmaceuticals announces 'positive' results with RXI-231 in testing program »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$0.54

0.0275 (5.35%)

07:07
11/13/17
11/13
07:07
11/13/17
07:07
Hot Stocks
RXi Pharmaceuticals, Gustave Roussy announce research collaboration »

RXi Pharmaceuticals and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
RXII

RXi Pharmaceuticals

$0.52

-0.0028 (-0.54%)

16:31
09/15/17
09/15
16:31
09/15/17
16:31
Hot Stocks
RXi Pharmaceuticals CBO Eliseev to leave company »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.